Incannex Healthcare (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare (ASX: IHL)
Latest News
Healthcare Shares
Why was the Incannex share price put on ice today?
Cannabis Shares
Looking to buy ASX cannabis shares right now? You'll want to watch this
Healthcare Shares
Why did the Incannex share price go up in smoke in October?
Cannabis Shares
Why is everyone talking about ASX cannabis shares all of a sudden?
Healthcare Shares
Is ASX 300 healthcare company Incannex profitable?
Share Gainers
Why has the Incannex share price rallied 20% in 2 weeks?
Healthcare Shares
Have Incannex Healthcare shares been a good investment in 2022?
Healthcare Shares
Why the Incannex share price leapt 13% on Monday?
Share Gainers
Up 35% in a month, is the Incannex share price on the comeback trail?
Cannabis Shares
Can ASX cannabis shares ever fully recover?
Share Gainers
Why is the Incannex share price spiking 8% on Tuesday?
Healthcare Shares
'World's largest portfolio': Why this ASX cannabis share is up 36% in August
Frequently Asked Questions
-
Incannex listed on the ASX in May 2007.
-
No, Incannex has not yet paid out any dividends.
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare
Incannex Healthcare Ltd (ASX: IHL) is a developer of cannabinoid and psychedelic compound medicines. It is currently involved in clinical programs for the treatment of six conditions: Obstructive Sleep Apnea (OSA), Generalised Anxiety Disorder (GAD), traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
The company has an Australian license to import, export, and distribute medicinal cannabis products and has a line of cannabinoid products.